Selected article for: "cell cycle and virus infection"

Author: Munday, Diane C.; Emmott, Edward; Surtees, Rebecca; Lardeau, Charles-Hugues; Wu, Weining; Duprex, W. Paul; Dove, Brian K.; Barr, John N.; Hiscox, Julian A.
Title: Quantitative Proteomic Analysis of A549 Cells Infected with Human Respiratory Syncytial Virus
  • Document date: 2010_7_20
  • ID: 2zhaknbi_3
    Snippet: During infection, the virus has multiple effects on the host cell. These include (but are not limited to) cell cycle arrest through the up-regulation of transforming growth factor ␤1 (18) , alterations in the composition of lipid raft membranes (19) , decreases in members of the IFN pathways such as TRAF3 (TNF receptor-associated factor 3) and STAT2 (signal transducers and activators of transcription protein 2) (20) , activation of the NF-B sig.....
    Document: During infection, the virus has multiple effects on the host cell. These include (but are not limited to) cell cycle arrest through the up-regulation of transforming growth factor ␤1 (18) , alterations in the composition of lipid raft membranes (19) , decreases in members of the IFN pathways such as TRAF3 (TNF receptor-associated factor 3) and STAT2 (signal transducers and activators of transcription protein 2) (20) , activation of the NF-B signal transduction pathway (21, 22) , and the activation of innate immunity through Toll-like receptor 2 (23) . Many of these processes are regulated by the induction of different gene subsets (24) . The relative level of host cell proteins can have a direct effect on HRSV disease progression where secondary bacterial infections are observed. For example, aberrant expression of a mucosal ␤-defensin leads to bacterial colonization by Haemophilus influenzae in HRSV infection (25) .

    Search related documents:
    Co phrase search for related documents
    • aberrant expression and cell protein: 1
    • aberrant expression and disease progression: 1, 2
    • aberrant expression and growth factor: 1, 2, 3
    • aberrant expression and host cell: 1, 2, 3, 4
    • aberrant expression and host cell protein: 1
    • aberrant expression and innate immunity: 1
    • aberrant expression and signal transduction: 1
    • activator signal transducer and cell cycle: 1, 2, 3, 4, 5, 6, 7
    • activator signal transducer and cell cycle arrest: 1, 2, 3, 4
    • activator signal transducer and cell protein: 1, 2, 3
    • activator signal transducer and direct effect: 1, 2
    • activator signal transducer and disease progression: 1, 2, 3
    • activator signal transducer and growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • activator signal transducer and host cell: 1, 2
    • activator signal transducer and IFN pathway: 1, 2, 3, 4, 5, 6, 7, 8
    • activator signal transducer and innate immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activator signal transducer and innate immunity activation: 1, 2
    • activator signal transducer and signal transducer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • activator signal transducer and signal transduction: 1, 2, 3, 4, 5, 6